What do branded GLP-1 medications cost without insurance?
The branded FDA-approved GLP-1 weight management drugs carry high list prices without insurance coverage. Wegovy (branded semaglutide approved for weight management) has a published list price of approximately $1,350 per month. Zepbound (branded tirzepatide approved for weight management) carries a similar list price in the $1,000 to $1,400 per month range. These figures represent what an uninsured patient would pay out of pocket for the branded product at a retail pharmacy.
Novo Nordisk and Eli Lilly both operate savings card programs for commercially insured patients that reduce out-of-pocket costs significantly. But patients without insurance, those on Medicare, and those with plans that exclude weight-loss drugs from formulary typically have no access to those savings cards. For many uninsured patients, $1,000 to $1,400 per month is the realistic out-of-pocket figure.
What does compounded GLP-1 cost without insurance?
Compounded semaglutide and compounded tirzepatide from licensed 503Acompounding pharmacies are available through telehealth platforms at a significantly lower price. The typical range is $150 to $450 per monthdepending on dose tier and platform.
This lower GLP-1 cost without insurance reflects the absence of brand-drug development costs, patent premiums, and marketing expenses built into the price of FDA-approved branded products. Compounded semaglutide is a preparation of semaglutide active pharmaceutical ingredient (API) prepared by a licensed compounding pharmacy — it is not an FDA-approved drug, and it is not therapeutically equivalent to Wegovy or Ozempic.
The legal basis for access is the FDA shortage exemption. While Wegovy and Ozempic have appeared on the FDA shortage list, licensed 503A compounding pharmacies may compound semaglutide under that framework. Patients and clinicians should monitor the FDA shortage status, as the availability of compounded versions is tied to that designation.
What does the monthly cost actually include?
When a telehealth platform quotes a monthly GLP-1 cost, understanding what that price covers is important. The components vary across platforms:
- Medication: The compounded semaglutide or tirzepatide itself, dispensed from a licensed 503A pharmacy. This is the core of the monthly price. Injection supplies (syringes, alcohol wipes) may or may not be bundled.
- Clinician consultation fee: The initial clinical review of your intake. Most platforms charge this as a separate one-time fee ranging from $49 to $149. Some bundle it into the first month's medication price. Some platforms charge recurring consultation fees at each refill or check-in.
- Ongoing monitoring: Access to your clinical team between monthly shipments, dose adjustment consultations, and any platform-facilitated lab work. Quality varies significantly across platforms.
- Shipping: Cold-chain shipping for injectable medications. May be included or billed as a flat fee per shipment. Confirm before starting.
A realistic all-in total monthly cost for a telehealth compounded GLP-1 program — medication, consultation, and shipping — is $200 to $400 per monthat low to moderate dose tiers. Higher maintenance doses will cost more. Getting the full dose-tier pricing grid from any platform before committing is the right approach.
The cost gap between branded and compounded GLP-1 is structural, not clinical — often 70 to 85 percent, driven by patent and marketing overhead, not oversight.
Does insurance cover GLP-1 weight-loss medication?
Insurance coverage for GLP-1 medications is complicated and often disappointing for patients hoping it will reduce their costs.
Commercial insurance: Coverage for GLP-1 weight management drugs varies by employer plan. Many commercial plans exclude weight-loss drugs from their formulary entirely, especially self-insured employer plans. Where coverage exists, prior authorization is nearly universal and frequently requires documentation of BMI thresholds, comorbidities, and prior weight-loss program participation.
Medicare: Medicare Part D does not cover drugs prescribed primarily for weight management under current law. Ozempic and Mounjaro (the type 2 diabetes-indicated versions of semaglutide and tirzepatide) may be covered for Medicare beneficiaries with a diabetes diagnosis, but that coverage pathway is not available for weight management without diabetes.
Medicaid: Coverage varies significantly by state. Some state Medicaid programs cover GLP-1 medications for qualifying patients; others do not.
Compounded medications: Commercial insurance plans do not cover compounded medications. Compounded semaglutide and tirzepatide are always out-of-pocket costs regardless of insurance status.
How does compounded GLP-1 cost compare to branded options?
For most patients considering GLP-1 therapy without strong insurance coverage, the cost math favors compounded options:
| Option | Monthly cost (no insurance) | Notes |
|---|---|---|
| Branded Wegovy (semaglutide) | ~$1,350/mo | Savings card for commercially insured only |
| Branded Zepbound (tirzepatide) | ~$1,000–$1,400/mo | Eli Lilly self-pay vial program available at select doses |
| Compounded semaglutide (503A telehealth) | $150–$450/mo | Always out-of-pocket; not FDA-approved |
| Compounded tirzepatide (503A telehealth) | $200–$500/mo | Always out-of-pocket; not FDA-approved |
The GLP-1 cost without insurance through compounded telehealth programs is typically 70 to 85 percent lowerthan the uninsured cost of branded alternatives. That gap reflects the structural difference between branded drug pricing and compounding pharmacy pricing, not a difference in clinical oversight quality — that depends entirely on the platform's clinical standards.
What should you verify before choosing a platform?
Lower GLP-1 cost without insurance is a meaningful advantage. But price should not be the only factor. Before starting a compounded GLP-1 program, confirm:
- Licensed 503A pharmacy sourcing: Your medication should be compounded in the USA by a licensed 503A pharmacy. No hidden overseas supply chain. Ask explicitly if the source pharmacy is 503A-licensed and domestic.
- Real clinical review: A licensed clinician should review your intake and medical history before issuing a prescription. Automated approval without a human clinician is not a compliant program.
- Full dose-tier pricing grid: The price at your starting dose is not the price you will pay at maintenance. Get the complete grid.
- Ongoing monitoring pathway: What happens when you have a side effect? How do you reach your clinical team? A program without a reliable monitoring pathway is just a pharmacy delivery service.